|
Market Closed -
NYSE
16:00:00 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 0.4750 USD | -4.19% |
|
-15.93% | -64.81% |
| 08-17 | Maxim Group Downgrades cbdMD to Hold From Buy | MT |
| 08-13 | CbdMD, Inc., Q3 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 5.2M 4.49M 4.22M 3.84M 7.22M 497M 7.33M 49.49M 19.37M 249M 19.54M 19.12M 830M | P/E 2026 * |
-1.44x | P/E 2027 * | -1.28x |
|---|---|---|---|---|---|
| Enterprise Value | 5.2M 4.49M 4.22M 3.84M 7.22M 497M 7.33M 49.49M 19.37M 249M 19.54M 19.12M 830M | EV / Sales 2026 * |
0.24x | EV / Sales 2027 * | 0.23x |
| Free-Float |
83.69% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: cbdMD, Inc.
| 1 day | -4.19% | ||
| 1 week | -15.93% | ||
| Current month | -6.29% | ||
| 1 month | -23.01% | ||
| 3 months | -38.09% | ||
| 6 months | -32.26% | ||
| Current year | -64.81% |
| 1 week | 0.47 |  | 0.62 |
| 1 month | 0.46 | | 0.62 |
| Current year | 0.46 | | 1.34 |
| 1 year | 0.46 | | 2.56 |
| 3 years | 0.46 | | 13.84 |
| 5 years | 0.46 | | 882 |
| 10 years | 0.46 | | 2,606.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
T. Kennedy
CEO | Chief Executive Officer | 47 | 2023-02-28 |
Zeb Booker
CTO | Chief Tech/Sci/R&D Officer | - | 2018-12-31 |
Sibyl Swift
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Bakari Sellers
BRD | Director/Board Member | 41 | 2017-02-28 |
William Raines
BRD | Director/Board Member | 66 | 2019-04-18 |
Scott Stephen
CHM | Chairman | 60 | 2022-06-02 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/17/25 | Crc Investment Fund LP
| Sell | Company | 550,701 | 6.1787% | |
| 11/28/25 | Free | Chief Executive Officer | 445,000 | 4.9927% | ||
| 5/16/25 | Free | Chairman | 1,572 | 0.0251% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.19% | -15.93% | -37.19% | -95.09% | 5.2M | |
| +0.25% | -0.22% | +68.73% | +116.60% | 1,052B | |
| +0.78% | +1.21% | +48.53% | +52.20% | 627B | |
| +0.35% | +1.74% | +21.11% | +65.18% | 441B | |
| +0.28% | -3.05% | +39.10% | +36.65% | 349B | |
| +0.78% | -2.05% | +24.03% | +36.97% | 287B | |
| +0.87% | -2.82% | -0.28% | +6.27% | 241B | |
| +1.00% | +2.05% | +41.46% | +58.24% | 224B | |
| -0.78% | -4.16% | -10.28% | -53.87% | 202B | |
| +0.40% | +4.29% | +17.36% | +78.10% | 172B | |
| Average | -0.05% | -1.92% | +21.26% | +30.13% | 359.52B | |
| Weighted average by Cap. | +0.41% | -0.63% | +39.71% | +62.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.92M 18.93M 17.78M 16.19M 30.41M 2.1B 30.86M 208M 81.59M 1.05B 82.3M 80.52M 3.49B | 22.92M 19.79M 18.59M 16.92M 31.8M 2.19B 32.26M 218M 85.29M 1.1B 86.04M 84.18M 3.65B |
| Net income | -3.33M -2.88M -2.7M -2.46M -4.62M -319M -4.69M -31.68M -12.4M -160M -12.51M -12.24M -531M | -4.03M -3.48M -3.27M -2.97M -5.59M -385M -5.67M -38.29M -14.99M -193M -15.12M -14.79M -642M |
| Net Debt | - | - |
Employees
42
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-17 | US$0.4750 | -4.19% | 100,469 |
| 26-08-14 | US$0.4958 | -12.26% | 496,992 |
| 26-08-13 | US$0.5650 | -5.52% | 223,647 |
| 26-08-12 | US$0.5980 | +2.22% | 203,054 |
| 26-08-11 | US$0.5850 | +3.36% | 175,854 |
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.4958USD
Average target price
2.000USD
Spread / Average Target
+303.43%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- YCBD Stock
Select your edition
All financial news and data tailored to specific country editions
